DivorceTree's upgrade notwithstanding, your post is little more than repeating an old news item.
Analysts get paid to make predictions, not on the basis of the outcome of their predictions.
Maybe NGSX will discover that capsaisin is the real deal and will cure cancer; don't bet on it, though.
Pipeline has NSG-198 and how much more? They company seems to have either put Cue10Zah on the sideline or has given up on that product. Where's the beef?
No corrupt, I stand unconvinced. All IMHO.
Market Data 
Markets 
AI
